Michael J Bell1, P David Adelson, James S Hutchison, Patrick M Kochanek, Robert C Tasker, Monica S Vavilala, Sue R Beers, Anthony Fabio, Sheryl F Kelsey, Stephen R Wisniewski. 1. 1Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA. 2Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA. 3Safar Center for Resuscitation Research, University of Pittsburgh, Pittsburgh, PA. 4Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ. 5Department of Critical Care Medicine, University of Toronto, Toronto, CA. 6Department of Neurology, Harvard Medical School, Boston, MA. 7Department of Anesthesia, Harvard Medical School, Boston, MA. 8Division of Critical Care, Boston Children's Hospital, Boston, MA. 9Department of Anesthesia, University of Washington, Seattle, WA. 10Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA. 11Department of Epidemiology and Biostatistics, University of Pittsburgh, Pittsburgh, PA.
Abstract
OBJECTIVES: To describe the differences in goals for their usual practice for various medical therapies from a number of international centers for children with severe traumatic brain injury. DESIGN: A survey of the goals from representatives of the international centers. SETTING: Thirty-two pediatric traumatic brain injury centers in the United States, United Kingdom, France, and Spain. PATIENTS: None. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A survey instrument was developed that required free-form responses from the centers regarding their usual practice goals for topics of intracranial hypertension therapies, hypoxia/ischemia prevention and detection, and metabolic support. Cerebrospinal fluid diversion strategies varied both across centers and within centers, with roughly equal proportion of centers adopting a strategy of continuous cerebrospinal fluid diversion and a strategy of no cerebrospinal fluid diversion. Use of mannitol and hypertonic saline for hyperosmolar therapies was widespread among centers (90.1% and 96.9%, respectively). Of centers using hypertonic saline, 3% saline preparations were the most common but many other concentrations were in common use. Routine hyperventilation was not reported as a standard goal and 31.3% of centers currently use PbO(2) monitoring for cerebral hypoxia. The time to start nutritional support and glucose administration varied widely, with nutritional support beginning before 96 hours and glucose administration being started earlier in most centers. CONCLUSIONS: There were marked differences in medical goals for children with severe traumatic brain injury across our international consortium, and these differences seemed to be greatest in areas with the weakest evidence in the literature. Future studies that determine the superiority of the various medical therapies outlined within our survey would be a significant advance for the pediatric neurotrauma field and may lead to new standards of care and improved study designs for clinical trials.
OBJECTIVES: To describe the differences in goals for their usual practice for various medical therapies from a number of international centers for children with severe traumatic brain injury. DESIGN: A survey of the goals from representatives of the international centers. SETTING: Thirty-two pediatric traumatic brain injury centers in the United States, United Kingdom, France, and Spain. PATIENTS: None. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: A survey instrument was developed that required free-form responses from the centers regarding their usual practice goals for topics of intracranial hypertension therapies, hypoxia/ischemia prevention and detection, and metabolic support. Cerebrospinal fluid diversion strategies varied both across centers and within centers, with roughly equal proportion of centers adopting a strategy of continuous cerebrospinal fluid diversion and a strategy of no cerebrospinal fluid diversion. Use of mannitol and hypertonicsaline for hyperosmolar therapies was widespread among centers (90.1% and 96.9%, respectively). Of centers using hypertonicsaline, 3% saline preparations were the most common but many other concentrations were in common use. Routine hyperventilation was not reported as a standard goal and 31.3% of centers currently use PbO(2) monitoring for cerebral hypoxia. The time to start nutritional support and glucose administration varied widely, with nutritional support beginning before 96 hours and glucose administration being started earlier in most centers. CONCLUSIONS: There were marked differences in medical goals for children with severe traumatic brain injury across our international consortium, and these differences seemed to be greatest in areas with the weakest evidence in the literature. Future studies that determine the superiority of the various medical therapies outlined within our survey would be a significant advance for the pediatric neurotrauma field and may lead to new standards of care and improved study designs for clinical trials.
Authors: Kevin P Morris; Robert J Forsyth; Roger C Parslow; Robert C Tasker; Carol A Hawley Journal: Intensive Care Med Date: 2006-07-28 Impact factor: 17.440
Authors: Rebecca L Smith; John C Lin; P David Adelson; Patrick M Kochanek; Ericka L Fink; Stephen R Wisniewski; Hülya Bayir; Elizabeth C Tyler-Kabara; Robert S B Clark; S Danielle Brown; Michael J Bell Journal: Pediatr Crit Care Med Date: 2012-01 Impact factor: 3.624
Authors: Patrick M Kochanek; Nancy Carney; P David Adelson; Stephen Ashwal; Michael J Bell; Susan Bratton; Susan Carson; Randall M Chesnut; Jamshid Ghajar; Brahm Goldstein; Gerald A Grant; Niranjan Kissoon; Kimberly Peterson; Nathan R Selden; Robert C Tasker; Karen A Tong; Monica S Vavilala; Mark S Wainwright; Craig R Warden Journal: Pediatr Crit Care Med Date: 2012-01 Impact factor: 3.624
Authors: P David Adelson; John Ragheb; Paul Kanev; Douglas Brockmeyer; Sue R Beers; S Danielle Brown; Laura D Cassidy; Yuefang Chang; Harvey Levin Journal: Neurosurgery Date: 2005-04 Impact factor: 4.654
Authors: Jay Jagannathan; David O Okonkwo; Hian Kwang Yeoh; Aaron S Dumont; Dwight Saulle; Julie Haizlip; Jeffrey T Barth; John A Jane; John A Jane Journal: J Neurosurg Pediatr Date: 2008-10 Impact factor: 2.375
Authors: Anthony A Figaji; A Graham Fieggen; Ncedile Mankahla; Nico Enslin; Ursula K Rohlwink Journal: Childs Nerv Syst Date: 2017-08-14 Impact factor: 1.475
Authors: Haifa Mtaweh; Rebecca Smith; Patrick M Kochanek; Stephen R Wisniewski; Anthony Fabio; Monica S Vavilala; P David Adelson; Nicole A Toney; Michael J Bell Journal: Pediatr Crit Care Med Date: 2014-03 Impact factor: 3.624
Authors: Gitte Y Larsen; Michelle Schober; Anthony Fabio; Stephen R Wisniewski; Mary Jo C Grant; Nadeem Shafi; Tellen D Bennett; Deborah Hirtz; Michael J Bell Journal: Neurocrit Care Date: 2016-06 Impact factor: 3.210
Authors: Alexis A Topjian; Amber Stuart; Alyssa A Pabalan; Ashleigh Clair; Todd J Kilbaugh; Nicholas S Abend; Robert A Berg; Gregory G Heuer; Phillip B Storm; Jimmy W Huh; Stuart H Friess Journal: Neurocrit Care Date: 2014-10 Impact factor: 3.210